Olivia Martinez
Academic Appointments
- Professor (Research), Surgery - Multi-Organ Transplantation
- Member, Bio-X
- Member, Stanford Cancer Institute
- Member, Child Health Research Institute
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 498-6247Alternate Contact Sharon Dickow Administrative Associate Email Tel Work 8-6248
Professional Overview
Administrative Appointments
- Director, Graduate Program, Immunology IDP, Stanford University School of Medicine (2008 - present)
Honors and Awards
- Graduate Student Service Award, Stanford University School of Medicine (2011)
- Distinguished Service Award, American Association of Immunologists (2007)
- Faculty Mentor of the Year, Program in Immunology, Stanford University School of Medicine (2005)
- Fujisawa Basica Science Award, American Society of Transplantation (2004)
Professional Education
| Ph.D.: | Univ of California, Berkeley, Immunology (1982) |
| B.S.: | Univ of Southern California, Biological Sciences (1976) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
There are two major areas of focus in the laboratory. First, we are interested in Epstein Barr Virus-mediated mechanisms of immune evasion with particular focus on pathways that promote survival and proliferation of EBV B cell lymphomas, the characterization of the human T cell response to EBV-infected B cells and the identification of novel therapeutics for treatment of EBV B cell lymphomas. The second area of study addresses stem cell and solid organ transplantation. In particular we are examining mechanisms of graft rejection and immune regulation in allogeneic responses.
Publications
- Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant. 2013; (4): 883-90
- Changes in natural killer cell subsets in pediatric liver transplant recipients. Pediatr Transplant. 2012; (2): 176-82
- Differential expression of microRNAs during allograft rejection. Am J Transplant. 2012; (5): 1113-23
- Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder. Pediatr Transplant. 2012; (3): 220-9
- Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas. PLoS One. 2012; (8): e42610
- Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells. J Immunol. 2011; (1): 222-9
Help
Trial Administration